Ryan Rhodes, MD
Ophthalmology · Orangeburg, SCNPI 1013531045
Payments from drug & device makers
Across 76 payments — averaging $64.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Bausch & Lomb Americas Inc.$569
- AbbVie$556
- Sight Sciences, Inc.$444
- Johnson & Johnson Surgical Vision, Inc.$211
- Glaukos Corporation$173
- plus $987 from 11 others
What the payments were for
- Speaking & faculty fees$792%
- Food & beverage$4,71096%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 31 | $1,950 |
| Bausch & Lomb Americas Inc. | 11 | $569 |
| AbbVie(2 entities) | 8 | $556 |
| Sight Sciences, Inc. | 8 | $444 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $211 |
| Glaukos Corporation | 2 | $173 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $134 |
| Harrow Eye, LLC | 1 | $122 |
| Axogen | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Amgen | 1 | $113 |
| Carl Zeiss Meditec USA, Inc. | 2 | $112 |
| Astellas Pharma US Inc | 1 | $99 |
| NEW World Medical,inc. | 1 | $96 |
| Oyster Point Pharma, Inc. | 2 | $48 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$545
- Clareon$393
- OMNI(R) SURGICAL SYSTEM (US)$259
- STELLARIS$255
- enVista MX60 IOL$245
- XEN GLAUCOMA TREATMENT SYSTEM$206
- Unity$150
- NGENUITY$147
- Luxor$131
- ARGOS$129
- Flarex$122
- IHEEZO$122
- Verkazia$122
- Tobradex ST$122
- Natacyn$122
- AVANCE NERVE GRAFT$121
- SOFPORT AO$121
- EYLEA HD$114
- Tecnis IOL$112
How this compares
$4,890 in reported general payments places this provider in the 70th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RhopressaNetarsudil Mesylate | 43 | $16,480 |
| Prednisolone Acetate | 77 | $3,618 |
| Travoprost | 14 | $2,024 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 98 | $1,843 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $1,831 |
| Latanoprost | 214 | $1,772 |
| Ketorolac Tromethamine | 50 | $1,165 |
| Timolol Maleate | 69 | $764 |
| Dorzolamide Hcl | 29 | $746 |
| MoxifloxacinMoxifloxacin Hcl | 48 | $706 |
| Acetazolamide ErAcetazolamide | 12 | $595 |
| Brimonidine Tartrate | 43 | $390 |
| ErythromycinErythromycin Base | 15 | $164 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Orangeburg
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- John PayneWest Columbia$574K
- Mona CamacciCharleston$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.